Physician profile
Allen C Wegener
NPI 1790747129
$3,804.50
in general payments reported to CMS, 2019-2025
24 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $119 · 2021: $93.75 · 2022: $632 · 2023: $263 · 2024: $1,237 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825 · Travel and Lodging: $315 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.68 |
| Travel and Lodging | $315.27 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,124.94 | 2022-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $471.27 | 2019-2023 | Veozah |
| Janssen Biotech, INC. | $278.46 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Abbvie INC. | $278.20 | 2022-2024 | Botox |
| Boston Scientific Corporation | $251.96 | 2019-2025 | Axonics, General - Erectile Dysfunction, General - Female Sui |
| Intuitive Surgical, INC. | $211.61 | 2019-2024 | |
| Caldera Medical, INC | $186.22 | 2022-2023 | Desara |
| Ge Healthcare | $162.08 | 2025 | |
| Blue Earth Diagnostics | $134.19 | 2019-2022 | |
| Urovant Sciences INC | $129.33 | 2021-2022 | |
| Photocure INC | $119.29 | 2020 | |
| Dendreon Pharmaceuticals LLC | $92.45 | 2025 | Provenge |
| Myovant Sciences INC. | $72.49 | 2022 | |
| Sumitomo Pharma America, INC. | $62.55 | 2023 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $33.70 | 2019 | |
| Urogen Pharma, INC. | $28.23 | 2025 | |
| Allergan, INC. | $23.12 | 2019 | |
| Baxter Healthcare | $22.33 | 2019 | |
| Teleflex LLC | $19.24 | 2024 | Urolift |
| Ethicon US, LLC | $18.02 | 2019 | |
| Abc Home Medical Supply, INC. | $17.05 | 2024 | |
| Hollister Incorporated | $17.05 | 2024 | |
| Olympus America INC. | $15.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Wegener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.